What it is
Exosomes are extracellular vesicles, packets far smaller than a cell, that carry signalling molecules from one cell to another. In the body they are part of how cells coordinate repair and communication. In aesthetic medicine, the exosome preparations used are most often applied to the skin immediately after a procedure that has opened it, usually microneedling or a laser session. The disruption gives the particles a route into the dermis, where they can influence how the skin behaves during the recovery window.
That timing is the point. Applied to intact skin, most of a large molecule stays on the surface. Applied in the short window after controlled injury, when the barrier is briefly open and the skin is already in repair mode, the same preparation reaches the layer where the signalling can matter. This is why exosomes are almost always discussed as a partner to another treatment rather than a treatment on their own.
It is worth being honest about what an exosome product is, because the term covers a wide range. Source, processing and concentration vary between preparations, and the category is young enough that standards are still settling. Part of a doctor's job here is deciding not just whether exosomes fit the plan, but which preparation, and on what evidence.
What it does well
Where exosomes earn their place is in the quality of recovery after energy-based work, and as a regenerative layer inside a wider plan. After microneedling or a laser session, the skin is repairing, and the interest is in whether the signalling supports that process so the result settles well. Used this way, as an adjunct rather than the main event, they have a reasonable rationale and a growing, if still early, body of interest behind them.
There is also developing attention on their use in hair loss, where the signalling effect may support follicle activity. This part of the field is younger still, and the honest framing is interest rather than proof. Where hair is the concern, exosomes would sit inside a diagnosis-led plan, not stand in for one.
The steady way to read exosomes is as a supporting layer that may lift the quality of a result you are already getting from something else. That is a modest claim, and the accurate one here.
What it does not do, and who it is not for
Exosomes do not work as a primary treatment for lines, laxity, pigment or volume. They will not lift a jawline, fill a cheek, soften an established wrinkle or clear a sun spot on their own. The marketing around a stand-alone exosome facial sometimes implies otherwise, and the measured picture is that the evidence for exosomes used alone is thinner than the evidence for the base treatments they are paired with. If the concern is structural, the honest answer is a structural tool, with an adjunct only as a later question.
They are also the wrong starting point for anyone whose real problem has a clearer, better-established answer. If the diagnosis is volume loss, laxity, or a specific pigment, treating that directly comes first. Reaching for the newest category before the diagnosis is settled is the wrong order.
Some people should not have this treatment at a given visit. Because exosomes here are applied after the skin is deliberately opened, anyone with an active skin infection, an active breakout or an inflamed lesion at the treatment site should wait until the skin has settled. Anyone for whom the underlying microneedling or laser is not appropriate is not a candidate for the exosome layer either, since the base procedure carries the risk. And anyone who wants certainty, or who has read exosomes as a proven fix rather than a developing adjunct, is holding an expectation the science does not yet support.
Our view
Exosomes are a genuine area of interest, and they are also a category where enthusiasm has run ahead of the data. Both things are true at once. Dr Ong recommends them where they make sense, as a layered adjunct after microneedling or laser, and declines them where the case is a stand-alone facial sold on more than it can carry.
The clinic's habit is to treat the diagnosis first and the trend never. If exosomes add something to a plan that is already right, that is a reasonable conversation. If they are being reached for because the category is new and busy, that is when a doctor should slow down. New is not the same as better, and the assessment is where the two get told apart.
We would rather under-claim and be right than oversell a young category and be caught out by it later. That is the posture here, and it will move as the evidence does.
Practical notes
Because exosomes are used as an add-on, the practical details follow whatever they are paired with. There is no separate exosome downtime to plan around. The recovery to expect is the recovery of the base treatment, the microneedling or the laser, and no longer. The exosome layer is applied within that same session.
Whether exosomes belong in your plan at all is an assessment question, decided with Dr Ong after the concern has been diagnosed. That conversation also covers which preparation, and the honest state of the evidence for your particular use. Suitability is not read off a brochure or a trend, and not before the skin has been seen.
